Article
Frontline Treatment for Advanced HR+/HER2- Breast Cancer
- Author:
- Kevin Kalinsky, MD
Publish date: March 23, 2023
Endocrine therapy plus a CDK4/6 inhibitor is now considered the standard of care for advanced HR+/HER2- breast cancer. Dr Kalinsky...